What is the most recent earnings date for HARP stock?
HARPOON THERAPEUTICS INC (HARP) last reported earnings on 11/9/2023.
NASDAQ:HARP • US41358P2056
Past quarterly earnings results for HARPOON THERAPEUTICS INC (HARP), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2023 | -0.46 | -3.26 | 85.90% | 86.86% | 4.45M | 4.311M | 3.22% | -67.33% |
| Q2 2023 | 0.30 | -3.48 | 108.62% | 105.66% | 20.22M | 5.251M | 285.07% | 143.61% |
| Q1 2023 | -3.10 | -3.91 | 20.72% | 50.00% | 8.58M | 4.906M | 74.89% | 45.18% |
| Q4 2022 | -5.50 | -4.76 | -15.50% | -733.33% | 4.09M | 7.184M | -43.07% | -5.54% |
| Q3 2022 | -3.50 | -5.74 | 39.06% | -586.27% | 13.62M | 5.675M | 140.00% | 204.02% |
| Q2 2022 | -5.30 | -5.76 | 7.91% | -919.23% | 8.3M | 7.099M | 16.92% | 42.12% |
| Q1 2022 | -6.20 | -5.56 | -11.49% | -1,575.68% | 5.91M | 8.243M | -28.30% | -34.41% |
| Q4 2021 | -0.66 | -0.43 | -52.61% | -46.67% | 4.33M | 6.754M | -35.89% | -42.19% |
| Q3 2021 | -0.51 | -0.53 | 3.47% | 3.77% | 4.48M | 6.43M | -30.33% | 15.17% |
| Q2 2021 | -0.52 | -0.44 | -17.36% | -1.96% | 5.84M | 7.076M | -17.47% | 111.59% |
| Q1 2021 | -0.37 | -0.45 | 17.60% | 27.45% | 9.01M | 6.737M | 33.74% | 173.03% |
| Q4 2020 | -0.45 | -0.55 | 18.32% | - | 7.49M | 5.284M | 41.75% | - |
| Q3 2020 | -0.53 | -0.51 | -4.92% | - | 3.89M | 5.607M | -30.62% | - |
| Q2 2020 | -0.51 | -0.48 | -5.31% | - | 2.76M | 5.756M | -52.05% | - |
| Q1 2020 | -0.51 | -0.42 | -21.10% | - | 3.3M | 7.356M | -55.14% | - |
Notes
HARPOON THERAPEUTICS INC (HARP) last reported earnings on 11/9/2023.
HARPOON THERAPEUTICS INC (HARP) beat EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, HARPOON THERAPEUTICS INC (HARP) has beaten EPS estimates in 3 out of 4 releases.